Charlie Teo is not the real issue – Effective cancer removal is – Digital Technology required, page-4

Convivo - gaining traction - first quarter call Zeiss


AA

A zonebourse.com

zonebourse

1

Rechercher action, indice, devise, matière pre

Q

Markus Weber (Executives)

So -- so hopefully, I understood it right. Otherwise, please correct me. So in MCS, actually, what we see is, first of all, the KINEVO is doing really very well since the feature set is so compelling. Because it's not only the KINEVO itself, it's also the [CLARUS], which is there. So that means the endoscope connected to that. Then we have the [CONVIVO]. So we are actually offering a full workflow here, and this is something where actually the momentum kicks in, also in the connection now with navigation here. So this is, I would call it, it's not only a COVID topic. It's really because the innovation is cutting edge. And actually, it's a leading product here.

On the other side, we see also now, and this is something which is now -- will come with our acquisition with Kogent and Katalyst that with the instruments and then also the conn X I

https://m.zonebourse.com/cours/acti...G-Q1-2023-Earnings-Call-Feb-10-2023-42956575/